Skip to main content
OpenTrials
Completed

NCT Number: NCT02827929

Efficacy of Education Programs in Patients With Chronic Airway Diseases

The objective of this study is to determine whether the systematic education on air way disease and inhalers in outpatient settings contributes to improve the quality of life.

Education has been known to be effective for management of chronic airway disease. However, the real benefits remain unclear. An organized education on the chronic airway disease is directed by primary care physicians, and the investigators evaluate the effectiveness of the education.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The present study is a prospective and interventional study comparing the outcomes of education program for one month.

A one month education program is composed of three visits (every two weeks follow-up ) during which subjects were taught about their diseases, action plans in acute exacerbation, and inhaler technique.

To evaluate the effectiveness of systematic education, questionnaires evaluating quality of life and satisfaction of education will be examined after each visit.

Asthma control test (ACT) in asthma, chronic obstructive pulmonary disease (COPD) assessment test (CAT) in COPD subjects were compared before and after education as an index of quality of life.

Educational effects were also measured, associated with improvement of their knowledge for chronic airway disease itself, proper use of inhaler technique, and satisfaction of subjects after education.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients diagnosed as asthma or COPD
  • Patients of over 20 years old
  • Patients who agree with voluntary informed consent
  • Patients who were prescribed inhaler medication as treatment option

Exclusion criteria

  • Patients who have comorbid disorders which can influence on the study result (e.g. severe cardiac or kidney disease, cancer, transplantation, bronchiectasis, tuberculous destroyed lung)
  • Pregnant women
  • Patients who refused to participate in the study

Treatment and study plan

Education

Behavioral

3 times systemic education program will be provided to patients were diagnosed as asthma or COPD by their physicians.

Primary outcomes

  1. Change in CAT score

    Time frame: one month

    The investigators examined change of quality of life through CAT in patient with COPD.

Secondary outcomes

  1. Change in ACT score

    Time frame: one month

    The investigators examined change of quality of life through Asthma control test in patient with asthma.

  2. Medical cost

    Time frame: one month

    The investigators will compare the total medical cost related COPD or asthma before education with that after education. (unit: Korean won, KRW)

  3. Compliance to Medication

    Time frame: one month

    Compliance is calculated as the ratio between the number of actual doses and the number of doses that should have been taken during the total treatment period. The investigators will compare the ratio before and after education about air way disease

  4. patients satisfaction score with the education program

    Time frame: one month

  5. physicians satisfaction score with the education program

    Time frame: one month

  6. the time of acute exacerbation

    Time frame: one month

Sponsors and collaborators

Lead sponsor

Konkuk University Medical Center

Other

Registry information

Important dates

Study start
2014
Primary completion
2015
Study completion
2016
First posted
Jul 11, 2016
Registry last updated
Jul 12, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.